Gary N. Schwartz, MD
Title(s):
Associate Professor of Medicine
Department(s):
Medicine
Education:
Stanford University, BA 1979Stanford University School of Medicine, MD 1985
Programs:
Norris Cotton Cancer Center
Websites:
http:
Contact Information:
Dartmouth Medical School
HB 7500
Hanover NH 03755
Office: Rubin Building-Room 519
Phone: 603-650-6700
Fax: 603-650-0474
Email: gary.n.schwartz@hitchcock.org
Assistant: Nadine Lunt
Asst. Phone: 603-650-8898
Professional Interests:
Cancer chemotherapy and endocrine therapy for breast cancer, signal transduction pathways in breast cancer, and new drug development.
Grant Information:
ZD1839 (Iressa) in Tamoxifen-Resistant Metastatic Breast Cancer, Principal Investigator, (NCI-NIH)
S14 as a Therapeutic Targetin Breast Cancer, Co-investigator, (DOD)
Courses Taught:
None
Selected Publications: |
|
Pendyala L. Schwartz G. Smith P. Zdanowicz J. Murphy M. Hausheer F Modulation of plasma thiols and mixed disulfides by BNP7787 in patients receiving paclitaxel/cisplatin therapy. Cancer Chemotherapy & Pharmacology. 51(5):376-84, 2003 May (view details in PubMed) Schwartz GN, Pendyala L, Kindler H, Meropol N, Perez R, Raghavan D, and Creaven P The clinical development of paclitaxel and the paclitaxel/carboplatin combination. Eur J Cancer 34(10):1543-1548, 1998 (view details in PubMed) Schwartz GN, Teicher BA, Eder JP, Korbut T, Holden SA, Ara G, Herman TS Modulation of antitumor alkylating agents by novobiocin, topotecan, and lonidamine. Cancer Chemotherapy and Pharmacology, 1993, 32:455-62 (view details in PubMed) |